The Use of Muscle Relaxants and Reversal Agents in a Setting Without Cost Restrictions: Experience from a Tertiary Academic Hospital in the Netherlands
Chris H Martini,1 GH Maarten Honing,1 Lori D Bash,2 Erik Olofsen,1 Marieke Niesters,1 Monique van Velzen,1 Albert Dahan,1 Martijn Boon1 1Department of Anesthesiology, Leiden University Medical Center, Leiden, the Netherlands; 2Center for Observational and Real- World Evidence (CORE), Merck & Co....
Main Authors: | Martini CH, Honing GHM, Bash LD, Olofsen E, Niesters M, van Velzen M, Dahan A, Boon M |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2022-04-01
|
Series: | Therapeutics and Clinical Risk Management |
Subjects: | |
Online Access: | https://www.dovepress.com/the-use-of-muscle-relaxants-and-reversal-agents-in-a-setting-without-c-peer-reviewed-fulltext-article-TCRM |
Similar Items
-
A Meta-Analysis on the Effect of Dexamethasone on the Sugammadex Reversal of Rocuronium-Induced Neuromuscular Block
by: Chang-Hoon Koo, et al.
Published: (2020-04-01) -
Half dose sugammadex combined with neostigmine is non-inferior to full dose sugammadex for reversal of rocuronium-induced deep neuromuscular blockade: a cost-saving strategy
by: Marie T. Aouad, et al.
Published: (2017-04-01) -
Sugammadex, the Guardian of Deep Muscle Relaxation During Conventional and Robot-Assisted Laparoscopic Surgery: A Narrative Review
by: Sun Y, et al.
Published: (2021-09-01) -
Effects of age on sugammadex reversal of neuromuscular blockade induced by rocuronium in Chinese children: a prospective pilot trial
by: Ruidong Zhang, et al.
Published: (2021-10-01) -
An appraisal of neostigmine versus sugammadex for neuromuscular blockade reversal in patients with a prior heart transplant
by: Stephania Paredes, et al.
Published: (2023-03-01)